期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 4, 期 3, 页码 338-343出版社
AMER CHEMICAL SOC
DOI: 10.1021/ml300407y
关键词
HIV; gp120; CD4; entry inhibitor; structure-based drug design; thermodynamics; X-ray crystallography; viral inhibition; protein-protein interactions
资金
- NIH [GM 56550, AI090682-01]
- NIH Intramural IATAP
- NIAID programs
- Ragon Institute of MGH
- Ragon Institute of MIT
- Ragon Institute of Harvard
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024755, R56AI090682] Funding Source: NIH RePORTER
- NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM056550] Funding Source: NIH RePORTER
The design, synthesis, thermodynamic and crystallographic characterization of a potent, broad spectrum, second-generation HIV-1 entry inhibitor that engages conserved carbonyl hydrogen bonds within gp120 has been achieved. The optimized antagonist exhibits a submicromolar binding affinity (110 nM) and inhibits viral entry of clade B and C viruses (IC50 geometric mean titer of 1.7 and 14.0 mu M, respectively), without promoting CD4-independent viral entry. The thermodynamic signatures indicate a binding preference for the (R,R)- over the (S,S)-enantiomer. The crystal structure of the small-molecule/gp120 complex reveals the displacement of crystallographic water and the formation of a hydrogen bond with a backbone carbonyl of the bridging sheet. Thus, structure-based design and synthesis targeting the highly conserved and structurally characterized CD4-gp120 interface is an effective tactic to enhance the neutralization potency of small-molecule HIV-1 entry inhibitors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据